December 23, 2024

FDA Grants Accelerated Approval to Encorafenib Combination for BRAF V600E–Mutant Metastatic Colorectal Cancer

On December 20, 2024, the U.S. Food and Drug Administration granted accelerated approval to encorafenib (Braftovi) in combination with cetuximab and modified fluorouracil, leucovorin, and oxaliplatin ...

The ASCO Post

December 13, 2024

My Cancer Diagnosis and Renewed Commitment to Fight for Patients

Ellen V. Sigal, founder of Friends of Cancer Research, reflects on her recent cancer diagnosis and the need to ensure that all patients can access the care that they need, without first having to over...

The ASCO Post

December 09, 2024

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

After the positive results of the monarchE and NATALEE trials, the necessity of neoadjuvant chemotherapy is being questioned in HR-positive, HER2-negative early breast cancer. Kazuki Nozawa, MD, of Na...

The ASCO Post

December 09, 2024

Accelerated Approval Granted to Zanidatamab-hrii for HER2-Positive Biliary Tract Cancer

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to zanidatamab-hrii (Ziihera), a bispecific HER2-directed antibody, for previously treated, unresectable or metastatic...

The ASCO Post

December 05, 2024

FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer

On December 4, 2024, the U.S. Food and Drug Administration approved durvalumab (Imfinzi) for adults with limited-stage small cell lung cancer (SCLC) whose disease has not progressed following concurre...

The ASCO Post

January 12, 2024

Changing Medical Practice Through Translational Research Successes

Converting data and science into medical progress requires a strategic emphasis on work that matters to patients, either through imminent application to clinical practice or potentially transformative basic discoveries.

Cedars-Sinai Pulse

July 06, 2023

Faculty Publications: June 29-July 6

This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published June 29-July 6.

Cedars-Sinai Pulse

May 09, 2023

Fibula free flap (free tissue transfer) for mandibular reconstruction

Mayo Clinic otolaryngologist Eric J. Moore, M.D. demonstrates a fibular free flap reconstruction of a mandibular defect following an oncologic resection for oral cavity cancer.

Mayo Clinic

December 06, 2023

'Game-Changer’ Intervention for Ovarian Cancer Prevention

Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.

Johns Hopkins Medicine